The pharmaceutical industry has been a subject of constant change and development over generations. And now, as we stand in a time when the whole world is making its way out from the pandemic aftershock, there is an increasing demand for pharmaceutical material also. The Pharmaceutical industry will see double digit growth this year. PCD pharma companies are also showing good upward trends and will be growing with equal pace. Due to covid 19 pcd pharma companies have shown very good sales in chronic segments which was once dominated by few companies. Pcd pharma have also shown very good growth in immunity boosting neutraceutical products, herbal and analgesic segment.
“Avonic Life Sciences is now poised to take a leap in to many other segments. Our global mission is to innovate for success. Our Team Every individual in our family has a right to a healthy life. Managed by professionals and with single mission of success for all, the head of the family has established the image of being supportive to each one. Avonic Life Sciences has travelled this noble cause in to a successful mission by introducing specialized products. Our many brands have already made their mark in various therapeutic segment, with the introduction of latest Psychiatry range.
We have done the basic research and committed to introduce the new molecules for better clinical efficacy. Avonic Life Sciences has emerged as a leader in the haematinic segment. Our entire liquid range is modified with the international standards in formulation and taste for the benefits to patients”, states Munish Aggarwal, CEO, Avonic Life Sciences.
Assurance of Quality
Quality has been the company’s major focus since inception. With government law becoming tougher day by day regarding quality they are ensuring that customers get quality products. 90 percent of their products are been manufactured in WHO CERTIFIED plants only. They have recently started giving quality analysis certificates to all esteemed customers along with stock. Avonic’s philosophy has always been giving value for money to all its customers. They have always strived to give quality products at competitive rates. During initial period of lockdown covid care products were in hugh demand and very selling at very high price and they did their best to give best quality products at less than market price to customers.
Avonic’s philosophy has always been giving value for money to all its customers. They have always strived to give quality products at competitive rates
Avonic Life Sciences is well poised to meet the challenges arising due to covid 19 and growing at a very fast pace. We have launched over 100 molecules in current financial year and now marketing over 400 plus molecules. Having an experience of over 20 years working in field has helped me to plan our marketing strategy according to market demands arising from time to time”, says the CEO.
Roadmap Ahead
The company has been grown by almost 45 percent during last year and the CEO plans to make it better in future course of time. “We want to achieve and sustain our position in pharmaceutical health care company. Our continuous improvement translates into success and benefits for our team, our customers and communities. We always prefer to introduce new and upcoming molecules to make our customer more secure in Doctor's chamber and in the trade. We are committed to provide the quality products at very competitive rates. We are also committed to total customer satisfaction by meeting the exact requirements of the customers in shortest reasonable time .we promise to deliver the products on time for each order”, he concludes.
.jpg "Artificial Intelligence to Revolutionize Advanced Chip Design")
